Countermeasures Season 3 Episode 2: Orthopoxviruses
The very fact that we are no longer vaccinating population against smallpox is a danger. — Dr. Martin...
Countermeasures Season 3 Episode 1: Vector-Borne Diseases
Vector-borne diseases are a tremendous global health concern, mostly because of how widespread they are and how prevalent they are. Globally, about three out of every four people live at risk...
Strategic Manufacturing Partnerships at Emergent: Close Collaboration to Enhance Public Health
As therapies become increasingly personalized, technically demanding and costly to develop, we recognize that a purely transactional manufacturing model falls short of providing the deep technical...
Countermeasures Season 3 Preview
As biological threats, natural or manmade, enjoy a freedom of global movement like never before. In season three of Countermeasures, we’ll take a closer look at the factors shaping public health...
Emergent Partner Spotlight: Khushi Baby
What if digital health could be built not just for data entry, but to empower community health workers and health officials to drive real-time action? This is the question guiding Khushi Baby, a...
From Cost Center to Value Driver
At Emergent, we know that quality is critical to public health, patient trust and long-term business success. Yet across the life sciences industry, quality can often be seen as a cost to control...